These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26073104)

  • 21. Growth hormone and GnRHa combination therapy in the management of precocious puberty.
    Khadilkar VV; Khadilkar VV; Maskati GB
    Indian Pediatr; 2005 Jan; 42(1):57-60. PubMed ID: 15695861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotropin-Releasing Hormone Analogs for Treatment of Central Precocious Puberty in Children Younger than 2 Years of Age.
    Gohil A; Eugster EA
    J Pediatr; 2022 May; 244():215-218. PubMed ID: 34942182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty.
    Weise M; Flor A; Barnes KM; Cutler GB; Baron J
    J Clin Endocrinol Metab; 2004 Jan; 89(1):103-7. PubMed ID: 14715835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recommendations for the diagnosis and treatment of central precocious puberty].
    Group of Endocrine and Genetic Metabolic Diseases, Chinese Society Of Pediatrics, Chinese Medical Association
    Zhonghua Er Ke Za Zhi; 2003 Apr; 41(4):272-3. PubMed ID: 14754531
    [No Abstract]   [Full Text] [Related]  

  • 25. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined therapy with luteinizing hormone releasing hormone agonist (LHRHa) and growth hormone (GH) in central precocious puberty.
    Volta C; Regazzi C; Ndaka J; Vitale R; Bernasconi S
    Acta Biomed; 2005 Sep; 76(2):73-8. PubMed ID: 16350551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depot leuprolide acetate for treatment of precocious puberty.
    Parker KL; Lee PA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):689-91. PubMed ID: 2503536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of manipulation of puberty on growth.
    Lee PA
    Horm Res; 2003; 60(Suppl 1):60-7. PubMed ID: 12955020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J; Reynaud R; Czernichow P
    J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial male precocious puberty.
    Laue L; Cutler GB
    Curr Ther Endocrinol Metab; 1994; 5():296-9. PubMed ID: 7704737
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-term therapy with delayed-action LHRH-antagonist decapeptyl depot in girls with precocious puberty. Results of an international multicenter study].
    Sippell WG; Partsch CJ; Hümmelink R; Lorenzen F
    Gynakologe; 1991 Apr; 24(2):108-13. PubMed ID: 1835952
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacology and possibilities for use of gonadotropin releasing hormone analogs].
    Breckwoldt M; Zahradnik HP; Karck U
    Gynakologe; 1992 Aug; 25(4):241-6. PubMed ID: 1398253
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
    Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.
    Kamp GA; Manasco PK; Barnes KM; Jones J; Rose SR; Hill SC; Cutler GB
    J Clin Endocrinol Metab; 1991 Feb; 72(2):301-7. PubMed ID: 1991801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M; Bacopoulou I; Savva SC; Skordis N
    Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
    N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central precocious puberty complicating a virilizing adrenal tumor: treatment with a long-acting LHRH analog.
    Pescovitz OH; Hench K; Green O; Comite F; Loriaux DL; Cutler GB
    J Pediatr; 1985 Apr; 106(4):612-4. PubMed ID: 3884762
    [No Abstract]   [Full Text] [Related]  

  • 38. The treatment of precocious puberty.
    Wheeler MD; Styne DM
    Endocrinol Metab Clin North Am; 1991 Mar; 20(1):183-90. PubMed ID: 1827623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin-releasing hormone agonists. Current uses for these increasingly important drugs.
    Winkel CA
    Postgrad Med; 1994 May; 95(6):111-8. PubMed ID: 8170869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a luteinizing hormone-releasing hormone agonist.
    Klein KO; Baron J; Barnes KM; Pescovitz OH; Cutler GB
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2387-9. PubMed ID: 9661615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.